Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure

NCT02336737 is registered in ClinicalTrials.gov with Endomagnetics Inc as lead sponsor.

NCT NCT02336737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02336737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Lead sponsor
Endomagnetics Inc
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
December 31, 2015
Enrollment
160 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer